Company Profile
MANGOCEUTICALS Stock Price, News & Analysis
- Ticker:
- MGRX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Stock performance
0.36 USD (-1.32%)
Close
Last updated: July 13, 2026 at 00:00
6.27M USD
Market cap
Why the stock is moving
MGRX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
MANGOCEUTICALS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, MANGOCEUTICALS is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
MANGOCEUTICALS follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, MANGOCEUTICALS sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent related feed items are shown below in reverse chronological order.
- 01
USANA Schedules Second Quarter 2026 Earnings Release and Conference Call
USNA · Source: Usana Health Sciences, Inc.
- 02
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
ZBH · Source: Zimmer Biomet
- 03
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
ZBH · Source: Zimmer Biomet
- 04
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Mezigdomide in Patients with Relapsed or Refractory Multiple Myeloma
BMY · Source: BMYBristol-Myers Squibb Company
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of MANGOCEUTICALS (MGRX)?
MANGOCEUTICALS (MGRX) most recently closed at 0.36 USD, a -1.32% move versus the previous session.
What is the market cap of MANGOCEUTICALS (MGRX)?
MANGOCEUTICALS currently has a market capitalization of 6.27M USD on BioPharmSignal.
What does MANGOCEUTICALS do?
MANGOCEUTICALS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is MGRX stock listed?
MANGOCEUTICALS (MGRX) is associated with NASDAQ, United States, Biotechnology.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Which conditions is MANGOCEUTICALS targeting with Investors?
MANGOCEUTICALS is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.